Marcia Ignatow Berman, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 7901 Broadway, Room A1-9, Elmhurst, NY 11373 Phone: 718-334-4952 Fax: 718-334-4815 |
Shari Lobel, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 7901 Broadway, Room A1-9, Elmhurst, NY 11373 Phone: 718-334-4952 Fax: 718-334-4815 |
Dr. Betsy Jacobs, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 8940 56th Ave, Elmhurst, NY 11373 Phone: 718-335-5532 Fax: 718-505-0241 |
Be Ty Dy, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 9002 Queens Blvd, Elmhurst, NY 11373 Phone: 718-558-1283 |
Dr. Jay D Tartell, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 8940 56th Ave, Elmhurst, NY 11373 Phone: 718-335-5532 Fax: 718-505-0241 |
Joel Mollin, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 7901 Broadway, Room A1-9, Elmhurst, NY 11373 Phone: 718-334-4952 Fax: 718-334-4815 |
Dr. Craig J Youner, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 8940 56th Ave, Elmhurst, NY 11373 Phone: 718-335-5532 Fax: 718-505-0241 |
News Archive
A potential oral drug for rheumatoid arthritis (RA) may encourage women to treat their condition earlier rather than later because it is less arduous than currently available treatments. Early treatment is important because RA most often develops between the ages of 35 and 50 and is two- to three times more prevalent in women.
The body contains two types of fat cells, easily distinguished by color: White and brown. While white fat serves to store excess calories until they're needed by the body, brown adipocytes actually burn fat by turning it into heat.
ARxIUM, an industry-leading developer of pharmacy automation and workflow solutions, today announced the release of its newest RIVA automated IV compounding system.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiaries, Takeda Global Research & Development Center, Inc., and Takeda Global Research & Development Centre (Europe), Ltd., announced today the initiation of the Company's Phase 3 clinical trial program for TAK-875, an investigational therapy for type 2 diabetes.
Moderately elevated levels of insulin increase the levels of inflammatory markers and beta-amyloid in plasma and in cerebrospinal fluid, and these markers may contribute to Alzheimer's disease, according to a new study posted online today from Archives of Neurology, one of the JAMA/Archives journals.
› Verified 7 days ago